Navigation Links
Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
Date:7/21/2010

duct approval, either for full approval or accelerated approval purposes;
  • Improving standards for demonstrating safety and efficacy of rare disease products;
  • Improving communications processes for rare disease stakeholders;
  • Extending the Qualifying Therapeutic Discovery Project Tax Credit; and
  • Fully funding the Cures Acceleration Network (CAN).

  • John F. Crowley commented in his testimony, "We have come very far in the last quarter of a century but we have much further to go. The change brought about by the Orphan Drug Act improved millions of lives in this country and abroad, helped launch an industry and established the global rare disease advocacy movement. It does not come easily for every family that struggles with illnesses and then receives a life-altering diagnosis of a rare disease with no treatment or cure. However, each of us committed to orphan drug development, including the FDA and those responsible for seeing the Agency is appropriately funded, owes those families a more-than-fighting chance that their medical needs will be met."

    "Through his compelling personal story and his professional passion, John Crowley truly understands the importance of the Orphan Drug Act and the need for additional incentives to spur the development of breakthrough treatments for rare and orphan diseases," said BIO President and CEO Jim Greenwood. "The recommendations John made in his testimony today reflect the concerns and interests of our member companies who are actively researching the next generation of therapies and the patients and their families who so desperately need them."

    About Amicus Therapeutics

    Amicus Therapeutics is a biopharmaceutical company focused on developing treatments for rare d
    '/>"/>

    SOURCE Amicus Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
    2. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
    3. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
    4. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
    5. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
    6. Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
    7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
    8. Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
    9. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
    10. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
    11. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , December 24, 2014 ... Report on Global Disposable Syringe Industry of ... its online business intelligence library. ... Disposable Syringe Industry is a professional and ... market.  For overview analysis, the report introduces ...
    (Date:12/24/2014)... ALEXANDRIA, Va. , Dec. 23, 2014 /PRNewswire-USNewswire/ ... stringent diastolic blood pressure target for people with ... either moderate or high doses of statins, in ... risk management enacted by the American College of ... recommendations are reflected in the most recent changes ...
    (Date:12/24/2014)... HILL, N.C. , Dec. 23, 2014  Medical ... success. As the key link between the medical device ... grow even more in the coming years as the ... According to research by benchmarking firm, ... MSLs can gain an important edge is by harnessing ...
    Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Role of Medical Science Liaisons Evolving in Medical Device Sector 2
    ... CorMatrix® Cardiovascular, a medical device company dedicated to developing ... body,s innate ability to repair damaged cardiovascular tissue, announced today it ... Repair. With this designation, CorMatrix is now able to market this ... , , ...
    ... Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and CFO ... Global Healthcare Conference on Tuesday, June 15 , at 3:05 ... Los Angeles .  The presentation will be webcast on the following link: ... , Perrigo ...
    Cached Medicine Technology:CorMatrix(R) ECM(TM) Receives CE Mark for Cardiac Tissue Repair 2
    (Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
    (Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
    (Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
    (Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
    (Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... risk of death and heart attack can be reduced for ... the usual dose of an anti-clotting drug before the procedure ... a balloon-tipped catheter is threaded into an artery. The balloon ... the vessel. A small synthetic tube - stent is used ...
    ... It has been found out that there is no association ... food -- and breast cancer. More than 43,000 women were ... participants had their average daily intake of acrylamide monitored. No ... women whose intake was higher was documented. Acrylamide was first ...
    ... Session of the International Association for Dental Research held ... of a study// that says eating sugar-free yogurt is ... bad odor or so called bad breath is caused ... The study revealed that volunteers who had sugar-free more ...
    ... has found out that depression has to be blamed for ... to treat the same. The study was conducted on 60,000 ... results showed both the newer and older classes of antidepressants ... first month of being prescribed.The older class of tricyclic antidepressants ...
    ... of the drug tezosentan did not improve worsening heart failure ... despite high hopes. The above fact was found out in ... The study was conducted to evaluate if something more could ... speed up hospital discharge and prevent them from coming back. ...
    ... known to help in controlling obesity. A new study coming ... (2005) says that dietary calcium present in the yogurt has ... lipid utilization and decrease in lipogenesis. ,The ... group was put on balanced deficit diets and the other ...
    Cached Medicine News:
    ... Ankle/Brachial Index (ABI) testing, Nicolet Vascular has ... It includes a 10-minute compact disk ABI ... any computer with a CD drive. It ... ABI test, provides information on the materials ...
    ... Triad Skull Clamp, compatible with the full ... of clamping force on all three skull ... the possibility of adjusting the force on ... be increased or decreased by adjusting the ...
    ... Advanced engineering, rapid acquisition of data, ... it the most accurate autorefractor available. ... High Quality Monitor allows for easy ... are taken as soon as focus ...
    ... Clinitek Microalbumin Strips provide albumin, creatinine and ... Clinitek Microalbumin product is useful to test ... hypertension in order to detect early kidney ... of the urinary albumin excretion rate, is ...
    Medicine Products: